Sign Up to like & get
recommendations!
1
Published in 2017 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2017.07.001
Abstract: Teriflunomide is an oral therapy approved for relapsing forms of multiple sclerosis which has been shown to reduce relapse rate and disability progression. We report the case of a 54-year -old black woman with multiple…
read more here.
Keywords:
sclerosis;
case lymphoma;
patient teriflunomide;
lymphoma patient ... See more keywords